EUVIMEDEUVIMED entdecken
Open Access

Loss of cystatin C regulates permeability and inflammatory pathways in retina

Li Liu, Youde Jiang, Jena J Steinle

Microvascular Research · 2023

DOI: 10.1016/j.mvr.2023.104510 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microvascular Research, 2023. Verfasst von Li Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI 48201, USA. Hauptthemen laut MEDLINE: Endothelial Cells, Retinal Diseases. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS, NIDDK NIH HHS, National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystatin C has been linked to inflammation in other diseases, such as epilepsy and Alzheimer's disease. These studies were designed to investigate whether Cystatin C regulates retinal inflammation and permeability. To address this question, we used Cystatin C knockout mice in a retinal ischemia/reperfusion model to determine whether Cystatin C regulated retinal damage, as well as inflammatory mediators and retinal permeability. To support the mouse work, we also used primary retinal endothelial cells cultured in normal and high glucose. Ischemia/reperfusion in Cystatin C knockout mice caused increased formation of degenerate capillaries. Loss of Cystatin C increased fluorescein leakage in the retina, which was accompanied by reduced levels of zonula occludin 1 (ZO-1) and occludin proteins. When REC were grown in high glucose, recombinant Cystatin C decreased retinal permeability, while Cystatin C siRNA increased dextran flux compared to high glucose alone. Recombinant Cystatin C decreased levels of interleukin-1-beta (IL-1β) and high mobility group box 1 (HMGB1) levels. In conclusion, loss of Cystatin C increased vascular damage in response to ischemia/reperfusion. Cystatin C regulated permeability and inflammatory mediators in the retina in response to stressors. Cystatin C offers a new target for retinal disease therapeutic development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial CellsRetinal DiseasesMiceAnimalsOccludinCystatin CRetinaIschemiaMice, KnockoutInflammationCapillary PermeabilityGlucose

Stichwörter der Autor:innen

Cystatin CInflammationIschemia/reperfusionPermeability

Substanzen

OccludinCystatin CGlucose

Autor:innen und Institutionen

  • Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI 48201, USA.
  • Department of Ophthalmology, Visual, and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI 48201, USA. Electronic address: jsteinle@med.wayne.edu.

Förderung

  • NEI NIH HHS
  • NIDDK NIH HHS
  • National Eye Institute
  • Research to Prevent Blindness

Zitieren

APA

Liu, L., Jiang, Y., & Steinle, J. J. (2023). Loss of cystatin C regulates permeability and inflammatory pathways in retina. Microvascular Research. https://doi.org/10.1016/j.mvr.2023.104510

Vancouver

Liu L, Jiang Y, Steinle JJ. Loss of cystatin C regulates permeability and inflammatory pathways in retina. Microvascular Research. 2023. doi:10.1016/j.mvr.2023.104510

BibTeX
@article{Liu2023,
  author = {Liu, Li and Jiang, Youde and Steinle, Jena J},
  title = {Loss of cystatin C regulates permeability and inflammatory pathways in retina},
  journal = {Microvascular Research},
  year = {2023},
  doi = {10.1016/j.mvr.2023.104510}
}
Kostenlos starten →